Cough - Global Clinical Trials Review; H2, 2019

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The "Cough Global Clinical Trials Review, H2, 2019" clinical trials has been added to's offering.

This clinical trial report provides an overview of Cough clinical trials scenario.

Report Scope

    --  The report provides a snapshot of the global clinical trials landscape
    --  It provides top level data related to the clinical trials by Region,
        Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point
    --  The report reviews top companies involved and enlists all trials (Trial
        title, Phase, and Status) pertaining to the company
    --  The study provides all the unaccomplished trials (Terminated, Suspended
        and Withdrawn) with reason for unaccomplishment
    --  It provides enrollment trends for the past five years
    --  Lastly, it provides latest news for the past three months

Reasons to Buy

    --  Assists in formulating key business strategies with regards to
    --  Helps in identifying prominent locations for conducting clinical trials
        which saves time and cost
    --  Provides top level analysis of Global Clinical Trials Market which helps
        in identifying key business opportunities
    --  Supports understanding of trials count and enrollment trends by country
        in global therapeutics market
    --  Aids in interpreting the success rates of clinical trials by providing a
        comparative scenario of completed and uncompleted (terminated, suspended
        or withdrawn) trials
    --  Facilitates clinical trial assessment of the indication on a global,
        regional and country level

Key Topics Covered

    1. Report Guidance
    2. Clinical Trials Report Coverage
    3. Clinical Trials by Region
    4. Clinical Trials and Average Enrollment by Country
    5. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    6. Top Five Countries Contributing to Clinical Trials in Europe
    7. Top Countries Contributing to Clinical Trials in North America
    8. Top Five Countries Contributing to Clinical Trials in Middle East and
    9. Top Five Countries Contributing to Clinical Trials in Central and South
    10. Clinical Trials by G7 Countries: Proportion of Cough to Respiratory
        Clinical Trials
    11. Clinical Trials by Phase in G7 Countries
    12. Clinical Trials in G7 Countries by Trial Status
    13. Clinical Trials by E7 Countries: Proportion of Cough to Respiratory
        Clinical Trials
    14. Clinical Trials by Phase in E7 Countries
    15. Clinical Trials in E7 Countries by Trial Status
    16. Clinical Trials by Phase
    17. In Progress Trials by Phase
    18. Clinical Trials by Trial Status
    19. Clinical Trials by End Point Status
    20. Subjects Recruited Over a Period of Time
    21. Clinical Trials by Sponsor Type
    22. Prominent Sponsors
    23. Top Companies Participating in Cough Therapeutics Clinical Trials
    24. Prominent Drugs
    25. Clinical Trial Profile Snapshots

Companies Mentioned

    --  Merck & Co Inc
    --  C. H. Boehringer Sohn AG & Co KG

    --  GlaxoSmithKline plc

    --  Reckitt Benckiser Group plc
    --  Ligand Pharmaceuticals Inc
    --  Tris Pharma Inc
    --  Bayer AG

    --  AstraZeneca plc
    --  Glenmark Pharmaceuticals Ltd
    --  Pfizer Inc

For more information about this clinical trials report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets